CD1d

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

CD1d is a glycoprotein expressed on some cells containing antigens, such as in the case of intracellular infection. They activate natural killer cells.

The gamma herpesviruses Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus evade immune system detection and persist in B cells by down regulating the expression of CD1d, enabling them to avoid immune recognition by natural killer cells.[1][2][3]

Learn more

See also

References

  1. Sanchez, David Jesse; Gumperz, Jenny E.; Ganem, Don (May 2, 2005). "Regulation of CD1d expression and function by a herpesvirus infection". Journal of Clinical Investigation. 115 (5): 1369–1378. doi:10.1172/JCI200524041. ISSN 0021-9738. PMC 1087176. PMID 15864354.
  2. Chung, Brian K.; Tsai, Kevin; Allan, Lenka L.; Zheng, Dong Jun; Nie, Johnny C.; Biggs, Catherine M.; Hasan, Mohammad R.; Kozak, Frederick K.; van den Elzen, Peter (October 10, 2013). "Innate immune control of EBV-infected B cells by invariant natural killer T cells". Blood. 122 (15): 2600–2608. doi:10.1182/blood-2013-01-480665. ISSN 1528-0020. PMID 23974196.
  3. Priatel, John J; Chung, Brian K; Tsai, Kevin; Tan, Rusung (April 9, 2014). "Natural killer T cell strategies to combat Epstein–Barr virus infection". Oncoimmunology. 3. doi:10.4161/onci.28329. ISSN 2162-4011. PMC 4063158. PMID 25050206.